Literature DB >> 12475011

Brain control of the lower urinary tract.

Bertil F M Blok1.   

Abstract

The knowledge on neural pathways involved in micturition and continence has been expanded greatly the last ten years. The aim of the present review is to summarize results obtained from animal and human experiments and to discuss the pathophysiology of relevant urological dysfunction. Four specific parts of the mammalian neural system are important for the control of micturition and continence: 1) ganglion cells in the bladder wall and sympathetic chain (autonomic) and dorsal root chain (sensory); 2) motoneurons and sensory interneurons in the caudal spinal cord; 3) the caudal brainstem; and 4) the cortical and subcortical areas. The parts 1) to 3) comprise the basic components of the micturition reflex and are interconnected via peripheral nerves and central fiber tracts. Normally, we are continent for urine continuously, except for the necessary emptying of the bladder five to eight times a day. Specific lesions of the neural pathways can result in distinct types of urological dysfunction: hypoactivity or hyperactivity of the micturition or continence pathways, and a loss of control of the beginning of micturition.

Entities:  

Mesh:

Year:  2002        PMID: 12475011     DOI: 10.1080/003655902320765908

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  8 in total

Review 1.  Functional brain imaging and the bladder: new insights into cerebral control over micturition.

Authors:  Richard T Kershen; John Kalisvaart; Rodney A Appell
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 2.862

2.  Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder.

Authors:  Sung-Eun Kim; Mal-Soon Shin; Chang-Ju Kim; Ji-Hyeon Park; Kyung-Jin Chung; Han Jung; Khae-Hawn Kim; Jung-Hwan Lee; Il-Gyu Ko
Journal:  Int Neurourol J       Date:  2012-03-31       Impact factor: 2.835

3.  Inhibitory effects of endomorphin-2 on excitatory synaptic transmission and the neuronal excitability of sacral parasympathetic preganglionic neurons in young rats.

Authors:  Ying-Biao Chen; Fen-Sheng Huang; Ban Fen; Jun-Bin Yin; Wei Wang; Yun-Qing Li
Journal:  Front Cell Neurosci       Date:  2015-05-28       Impact factor: 5.505

4.  Protocol for a prospective neuroimaging study investigating the supraspinal control of lower urinary tract function in healthy controls and patients with non-neurogenic lower urinary tract symptoms.

Authors:  Matthias Walter; Lars Michels; Spyros Kollias; Philip E van Kerrebroeck; Thomas M Kessler; Ulrich Mehnert
Journal:  BMJ Open       Date:  2014-05-21       Impact factor: 2.692

5.  Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spinal Cord Injury.

Authors:  Jin-Hee Han; Sung-Eun Kim; Il-Gyu Ko; Jayoung Kim; Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

6.  Synaptic connections between endomorphin 2-immunoreactive terminals and μ-opioid receptor-expressing neurons in the sacral parasympathetic nucleus of the rat.

Authors:  Xiao Liang Dou; Rong Liang Qin; Juan Qu; Yong Hui Liao; Ya cheng Lu; Ting Zhang; Chen Shao; Yun Qing Li
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

7.  An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil.

Authors:  Sung-Eun Kim; Il-Gyu Ko; Lakkyong Hwang; In-Young Choi; Mal-Soon Shin; Chang-Ju Kim; Khae-Hawn Kim
Journal:  J Biomed Sci       Date:  2013-10-25       Impact factor: 8.410

8.  Effects of Panax ginseng on the nerve growth factor expression in testosterone induced benign prostatic hyperplasia.

Authors:  Su Kang Kim; Il GyuKo; Hae Jeong Park; Joo-Ho Chung; Kyu Bong Cho; Oh Young Kwon; Kyeong Hun Park; Young Sub Ahn; Chun Geon Park; Young Ock Kim
Journal:  Saudi J Biol Sci       Date:  2016-08-13       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.